Exclusive: Penn patient shares the story of her CAR-T cell therapy journey

Once given five weeks to live, Nicole Gularte's prognosis changed after she received a gene therapy treatment developed at Penn Medicine's Abramson Cancer Center.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news